Serial #79280902
LIVE

Serial Number

79280902

Owner

Alchemedicine Inc.

Attorney

Kathryn Swint

Filing Date

Jan 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79280902 Trademark

Serial Number: 79280902 • Registration: 6192190

Serial #79280902 is a trademark filed by Alchemedicine Inc. on January 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Alchemedicine Inc. (2 trademarks)

1-10-1, Azuma, Tsukuba-shi

Entity Type: 03

Trademark Details

Filing Date

January 14, 2020

Registration Date

November 10, 2020

Published for Opposition

August 25, 2020

Goods & Services

Testing, inspection, research or development services in the fields of pharmaceutical preparations, medicines, cosmetics and foodstuffs; advisory, consultancy and information services relating to testing, inspection, research or development of pharmaceutical preparations, medicines, cosmetics and foodstuffs; testing, inspection or research of chemical compounds and pharmaceutical compounds, and advisory, consultancy and information services relating thereto; chemical research and analysis services, and advisory, consultancy and information services relating thereto

Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment of cancer, musculo-skeletal disorders, immune system related diseases and disorders, gastro-intestinal diseases, cardiovascular disorders, central nervous system diseases, hypertension, blood disorders, pain, inflammation, metabolic disorders, genitourinary disorders, oncological disorders, hepatological disorders, kidney diseases, neurological disorders, inflammatory disorders, arthritis, and cognitive disorders; pharmaceutical preparations for use in urology, chemotherapy, and the field of oncology; pharmaceutical preparations acting on the central nervous system; anti-inflammatories; veterinary preparations, namely veterinary pharmaceutical preparations for the treatment of cancer, nervous system disorders, cardiovascular diseases, musculoskeletal disorders, gastrointestinal disorders, immune system diseases, genito-urinary system diseases, endocrine and metabolic system diseases, and inflammation; veterinary preparations, namely, pain relief medication; chemical preparations for pharmaceutical purposes for the treatment of cancer, musculo-skeletal disorders, immune system related diseases and disorders, gastro-intestinal diseases, cardiovascular disorders, central nervous system diseases, hypertension, blood disorders, pain, inflammation, metabolic disorders, genitourinary disorders, oncological disorders, hepatological disorders, kidney diseases, neurological disorders, inflammatory disorders, arthritis, and cognitive disorders; chemical reagents for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; sanitary preparations for medical purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 10, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 23, 2025 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 14, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 23, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 23, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 10, 2021 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2020 ADCH
REGISTERED-PRINCIPAL REGISTER
Nov 10, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 25, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 25, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 5, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 30, 2020 TROA
REFUSAL PROCESSED BY IB
May 9, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 20, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 20, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 7, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 6, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 20, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2020 REPR